mRNA vaccines offer a flexible and rapid production platform for personalized melanoma immunotherapy
mRNA Vaccines Show Promise for Treating Melanoma Cancer
This systematic review examines mRNA cancer vaccines, including lipid nanoparticle delivery systems, as potential treatments for melanoma. T…
New research highlights mRNA technology as a flexible and fast way to develop personalized treatments for melanoma patients.
ACIP Recommends Pfizer-BioNTech COVID-19 Vaccine for Children Aged 5-11 Years
CDC advisory panel recommends Pfizer COVID-19 vaccine for children ages 5 to 11
The ACIP has issued a recommendation for the Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years in the United States.
A CDC advisory panel now recommends the Pfizer COVID-19 vaccine for children ages 5 to 11 years in the United States.
ACIP issues interim recommendation for Pfizer COVID-19 vaccine in adolescents aged 12-15
Health panel issues interim recommendation for Pfizer COVID-19 vaccine in adolescents
The Advisory Committee on Immunization Practices issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolesc…
A U.S. health advisory committee recommends the Pfizer COVID-19 vaccine for adolescents aged 12-15 to help prevent the virus.